Annemarie Fioole‐Bruining

Impact of ¹⁸ <scp>F</scp> ‐fluorodeoxyglucose ( <scp>FDG</scp> )‐positron‐emission tomography/computed tomography ( <scp>PET</scp> / <scp>CT</scp> ) on management of patients with carcinoma invading bladder muscle

Laura S. Mertens, Annemarie Fioole‐Bruining, Erik Vegt et al. · British Journal of Urology · 2013 · 75 citations

Induction Chemotherapy Followed by Surgery in Node Positive Bladder Cancer

Richard P. Meijer, Laura S. Mertens, Bas W. van Rhijn et al. · Urology · 2013 · 61 citations

Urology, Surgical Oncology, Induction Chemotherapy Followed +6

FDG-Positron Emission Tomography/Computerized Tomography for Monitoring the Response of Pelvic Lymph Node Metastasis to Neoadjuvant Chemotherapy for Bladder Cancer

Laura S. Mertens, Annemarie Fioole‐Bruining, Bas W.G. van Rhijn et al. · The Journal of Urology · 2012 · 52 citations

18F-fluorodeoxyglucose–Positron Emission Tomography/Computed Tomography Aids Staging and Predicts Mortality in Patients With Muscle-invasive Bladder Cancer

Laura S. Mertens, Maria Carmen Mir, Andrew M. Scott et al. · Urology · 2014 · 45 citations

Urology, Oncologic Imaging, Medical Imaging +8

FDG-avid sclerotic bone metastases in breast cancer patients: a PET/CT case series

Bas B. Koolen, Erik Vegt, Emiel J. Rutgers et al. · Annals of Nuclear Medicine · 2011 · 33 citations

Bone Disease, Bone Imaging, Breast Cancer Patients +8